FCM
DVAX

Fourpath Capital Management’s Dynavax Technologies DVAX Stock Holding History

Fourpath Capital Management’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-115
Closed -$1.28K – 384
2024
Q3 		$1.28K Buy
+115
New +$1.27K ﹤0.01% 682

Other funds holding DVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fourpath Capital Management's DVAX Position: Q4 2024 in Review

Fourpath Capital Management sold out of Dynavax Technologies (DVAX) in Q4 2024, closing a stake of 115 shares — an estimated $1.28K sold.

Fourpath Capital Management first reported a position in DVAX in Q3 2024 and held it in 1 quarter. The position peaked at $1.28K in Q3 2024. 256 funds tracked by Wall St. Rank hold DVAX as of Q4 2024.

  • Fourpath Capital Management reported no remaining Dynavax Technologies position as of Q4 2024 after selling out during the quarter.
  • Fourpath Capital Management sold 115 Dynavax Technologies shares in Q4 2024, an estimated $1.28K.
  • Fourpath Capital Management first reported a position in Dynavax Technologies in Q3 2024 and held it in 1 quarter.
  • Fourpath Capital Management's Dynavax Technologies position peaked at $1.28K in Q3 2024.
  • 256 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2024.

Based on Fourpath Capital Management's 13F filing for Q4 2024, filed 24 Jan 2025.